UNRESECTABLE ADVANCED HBV-RELATED LIVER CANCER

Clinical trials for UNRESECTABLE ADVANCED HBV-RELATED LIVER CANCER explained in plain language.

Never miss a new study

Get alerted when new UNRESECTABLE ADVANCED HBV-RELATED LIVER CANCER trials appear

Sign up with your email to follow new studies for UNRESECTABLE ADVANCED HBV-RELATED LIVER CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Can adding interferon boost immunotherapy against liver cancer?

Disease control Recruiting now

This study tests whether adding pegylated interferon alpha-2b to standard targeted immunotherapy can help people with advanced liver cancer caused by hepatitis B. The trial enrolls adults with unresectable, intermediate-to-advanced disease who are already on antiviral therapy. Pa…

Matched conditions: UNRESECTABLE ADVANCED HBV-RELATED LIVER CANCER

Phase: NA • Sponsor: Jinling Hospital, China • Aim: Disease control

Last updated Aug 19, 2026 10:00 UTC

UNRESECTABLE ADVANCED HBV-RELATED LIVER CANCER

Get alerted when new UNRESECTABLE ADVANCED HBV-RELATED LIVER CANCER trials appear

Can adding interferon boost immunotherapy against liver cancer?